Xoma Gains With Servier Partnership
This article was originally published in The Pink Sheet Daily
Executive Summary
Xoma has signed a multi-faceted partnering agreement worth as much as $505 million with privately-held French pharmaceutical company Les Laboratoires Servier for its lead compound Xoma-052.